• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Medtronic launches data management software program for Synchromed II

January 23, 2020 By Danielle Kirsh

Medtronic logo updatedMedtronic (NYSE:MDT) this week launched a cloud-based data management software platform for its Synchromed II drug delivery system.

The Efficio platform is designed to allow clinicians to manage targeted drug delivery pump practices to treat patients who have chronic pain, cancer pain and severe spasticity. It consolidates, organizes and provides visual summaries of patient data received from the clinician programmer in a secure cloud environment. The information is accessible anywhere and at any time.

“For years, clinicians have been managing pump patients on their own with internal spreadsheets and other manual processes,” Chris Beuer, director of pain management at Christian Hospital in St. Louis, Mo., said in a news release. “Now, with the click of a button, I can understand the dosing history of an individual patient or produce end-of-day reports within minutes. Efficio also helps me manage pump refill dates, pump replacement and monitor trends in dosing and patient function. It provides tremendous value to my practice, allowing me to focus more time caring for my patients.”

Efficio is able to connect individual patient measurements and dosing trends for better therapy management insights. It also enables scheduling patient appointments, facilitates prescription drug order tracking for pump refills and can print reports on demand.

“Efficio marks another step in our journey to simplify targeted drug delivery therapy,” VP and general manager of target drug delivery at Medtronic Charlie Covert said. “We believe providing innovative solutions that simplify management of the therapy will enable clinicians to reduce pain or severe spasticity symptoms for even more patients with this proven therapy.”

Medtronic in October last year recalled an unspecified number of its SynchroMed II drug infusion pumps because of a possibility of malfunction. The company also warned in 2017 on batteries first issued in 2011 that could cause the pump to fail.

Filed Under: Drug-Device Combinations, Featured, Pain Management Tagged With: Medtronic

IN CASE YOU MISSED IT

  • FDA approves first targeted infusion therapy for HER2-low breast cancer
  • Abbott, WeightWatchers partner on diabetes care
  • Insulet up on Q2 sales beat, raised full-year guidance
  • Aptar acquires Orbital dry powder inhaler license
  • Tandem sinks on Q2 misses, slashed sales guidance

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS